Neuro-Bio is a start-up company focused on the development of novel, effective therapeutics for neurodegenerative disorders such as Alzheimer’s, Parkinson’s and Motor Neuron Disease. The Company’s uniqueness lies in its innovative identification of the initial trigger of neurodegeneration - this has been developed throughout Baroness Professor